Key facts
- Notable investors include Fujian Huaxing Venture Capital, Jiangsu Dongda Jinshan Capital Management, Shuangchuang Talents United.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Zhuwei Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhuwei Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhuwei Medicine
Manufacturer of neurosurgical medical devices aims to enhance precision and efficiency in neurosurgery. The company's offerings feature AI and big data-driven digital platforms for full-cycle disease management, intelligent diagnostic support, and surgical navigation, helping customers benefit from streamlined workflows and improved treatment accuracy, enabling the digital transformation of neurosurgical care.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Zhuwei Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhuwei Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhuwei Medicine in its N-PORT filings yet. We sweep new filings monthly.